Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

Thumbnail
Fulltext:
231606.pdf
Size:
1.462Mb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2021
Author(s)
Janssen, J.
Lowenberg, B.
Manz, M.
Bargetzi, Mario
Biemond, Bart J.
Borne, Peter von dem
Velden, W.J.F.M. van der
Norden, Yvette van
Ossenkoppele, G.J.
Source
Cancers, 13, 4, (2021), article 672
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/231606   https://hdl.handle.net/2066/231606
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.